Brain Involvement in Neuromyelitis Optica Spectrum Disorders

被引:85
|
作者
Chan, Koon Ho [1 ,2 ,3 ]
Tse, C. T. [1 ]
Chung, C. P. [1 ]
Lee, Raymand L. C. [1 ]
Kwan, J. S. C. [1 ,2 ]
Ho, P. W. L. [1 ,3 ]
Ho, J. W. M. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Neuroimmunol & Neuroinflammat Res Lab, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
关键词
INFLAMMATORY DEMYELINATING DISORDERS; RESONANCE-IMAGING ABNORMALITIES; ANTI-AQUAPORIN-4; ANTIBODY; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; CLINICAL-COURSE; WATER CHANNEL; IGG; NMO; RITUXIMAB;
D O I
10.1001/archneurol.2011.249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neuromyelitis optica spectrum disorders (NMOSDs) are severe inflammatory demyelinating disorders of the central nervous system. Brain involvement is increasingly recognized. Objective: To study brain involvement in NMOSDs among Hong Kong Chinese patients. Design: Retrospective study of patients with NMOSDs. Setting: Tertiary medical center in Hong Kong. Patients: Thirty-four Hong Kong Chinese patients with NMOSDs of 2 years or longer were recruited. Interventions: Brain and spinal cord magnetic resonance imaging was performed during NMOSD attacks and was repeated yearly for the first 3 years. Main Outcome Measures: We evaluated clinical features of NMOSDs associated with brain involvement and brain lesions on magnetic resonance imaging. Results: Among 34 patients with NMOSDs of 2 years or longer, 20 (59%) had brain involvement. The mean age at onset among these 20 patients was 45.6 years (age range, 19-67 years); 18 were women. Eleven patients (32% of all the patients with NMOSDs) had clinical manifestation of brain involvement, 19 patients (56%) had brain abnormalities on magnetic resonance imaging consistent with inflammatory demyelination, and 2 patients (6%) fulfilled criteria for multiple sclerosis. Clinical manifestation of brain involvement included the following: trigeminal neuralgia; vomiting, vertigo, ataxia, dysphagia, and tetraparesis from lesions around the third and fourth ventricles and aqueduct; homonymous hemianopia, aphasia, hemiparesis, and cognitive impairment from extensive hemispheric white matter lesions; and ataxia, diplopia, hiccups, facial sensory loss, internuclear ophthalmoplegia, hemisensory loss, and hemiparesis from other lesions in the midbrain, pons, cerebellar peduncles, and medulla. Eight patients (24%) developed brainstem encephalitis clinically, and brainstem encephalitis was the initial clinical manifestation in 6 patients (18%). Brain abnormalities on magnetic resonance imaging were detected in brainstem in 15 patients (44%), hemispheric periventricular white matter in 7 patients (21%), deep white matter in 7 patients (21%), corpus callosum in 4 patients (12%), subcortical white matter in 3 patients (9%), thalamus in 2 patients (6%), hypothalamus in 1 patient (3%), basal ganglia in 1 patient (3%), internal capsule in 1 patient (3%), periaqueductal gray matter in 1 patient (3%), and around the third and fourth ventricles in 1 patient (3%); large confluent lesions were detected in 2 patients (6%). Conclusion: Brain involvement manifesting clinically as brainstem encephalitis is common among Hong Kong Chinese patients with NMOSDs.
引用
收藏
页码:1432 / 1439
页数:8
相关论文
共 50 条
  • [21] Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
    Ciron, J.
    Audoin, B.
    Bourre, B.
    Brassat, D.
    Durand-Dubief, F.
    Laplaud, D.
    Maillart, E.
    Papeix, C.
    Vukusic, S.
    Zephir, H.
    Marignier, R.
    Collongues, N.
    REVUE NEUROLOGIQUE, 2018, 174 (04) : 255 - 264
  • [22] Risk factors of attacks in neuromyelitis optica spectrum disorders
    Akaishi, Tetsuya
    Takahashi, Toshiyuki
    Fujihara, Kazuo
    Misu, Tatsuro
    Abe, Michiaki
    Ishii, Tadashi
    Aoki, Masashi
    Nakashima, Ichiro
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 343
  • [23] Diagnosis and management of neuromyelitis optica spectrum disorders - An update
    Bruscolini, Alice
    Sacchetti, Marta
    La Cava, Maurizio
    Gharbiya, Magda
    Ralli, Massimo
    Lambiase, Alessandro
    De Virgilio, Armando
    Greco, Antonio
    AUTOIMMUNITY REVIEWS, 2018, 17 (03) : 195 - 200
  • [24] Voiding Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorders
    de Carvalho, Fabricio Leite
    Gomes, Cristiano Mendes
    Apostolos-Pereira, Samira L.
    Bessa, Jose, Jr.
    Pinheiro, Marcello
    Marchiori, Paulo E.
    Bruschini, Homero
    Srougi, Miguel
    Callegaro, Dagoberto
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (01) : 39 - 43
  • [25] Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
    Ramanathan, Ramnath Santosh
    Malhotra, Konark
    Scott, Thomas
    BMC NEUROLOGY, 2014, 14
  • [26] Serological markers associated with neuromyelitis optica spectrum disorders in South India
    Pandit, Lekha
    Sato, Douglas Kazutoshi
    Mustafa, Sharik
    Takahashi, Toshiyuki
    D'Cunha, Anitha
    Malli, Chaithra
    Sudhir, Akshatha
    Fujihara, Kazuo
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2016, 19 (04) : 505 - 509
  • [27] Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
    Fan, Xueli
    Jiang, Yanfang
    Han, Jinming
    Liu, Jingyao
    Wei, Yafen
    Jiang, Xinmei
    Jin, Tao
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [28] Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders
    Young, Victoria
    Quaghebeur, Gerardine
    SEMINARS IN ULTRASOUND CT AND MRI, 2016, 37 (05) : 384 - 395
  • [29] Differential diagnosis of neuromyelitis optica spectrum disorders
    Kim, Sung-Min
    Kim, Seong-Joon
    Lee, Haeng Jin
    Kuroda, Hiroshi
    Palace, Jacqueline
    Fujihara, Kazuo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (07) : 265 - 289
  • [30] Neuromyelitis optica spectrum disorders - laboratory examination
    Nytrova, P.
    Kral, V
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 : S31 - S36